Normal 0 false false false MicrosoftInternetExplorer4 Hyperion Therapeutics Inc (NASDAQ: HPTX) took on 1.7% to $14.56. The Company said that the U.S. Food and Drug Administration have advised the Company not to expect a final action by the Prescription Drug User Fee Act action date of January 23. Share volume was 12,000, compared to an all-day average of 8,300 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}